Authors: Grauer, JN Patel, TC Erulkar, JS Troiano, NW Panjabi, MM Friedlaender, GE

Citation: Jn. Grauer et al., Evaluation of OP-l as a graft substitute for intertransverse process lumbar fusion, SPINE, 26(2), 2001, pp. 127-133

Authors: Patel, TC Erulkar, JS Grauer, JN Troiano, NW Panjabi, MM Friedlaender, GE

Citation: Tc. Patel et al., Osteogenic protein-1 overcomes the inhibitory effect of nicotine on posterolateral lumbar fusion, SPINE, 26(15), 2001, pp. 1656-1661

Authors: Friedlaender, GE Perry, CR Cole, JD Cook, SD Cierny, G Muschler, GF Zych, GA Calhoun, JH LaForte, AJ Yin, S

Citation: Ge. Friedlaender et al., Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions - A prospective, randomized clinical trial comparing rhOP-1 with fresh bone autograft, J BONE-AM V, 83A, 2001, pp. S151-S158

Authors: Friedlaender, GE

Citation: Ge. Friedlaender, OP-1 clinical studies, J BONE-AM V, 83A, 2001, pp. S160-S161

Authors: Friedlaender, GE

Citation: Ge. Friedlaender, Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2 - Point of view, SPINE, 24(18), 1999, pp. 1871-1872

Authors: Friedlaender, GE

Citation: Ge. Friedlaender, New directions for section III of the journal, CLIN ORTHOP, (360), 1999, pp. 251-252